INTRODUCTION
The Wnt signaling pathway has prominent and widespread roles in development, tissue homeostasis, and cancer (MacDonald et al., 2009) . For example, Wnts coordinate proliferation and differentiation during organ growth and serve as extrinsic factors to regulate stem cells for tissue maintenance and regeneration (Clevers, 2006; Moon et al., 2004; Niehrs and Acebron, 2012) . Aberrant activation of the Wnt cascade is a major theme in cancer biology, leading to stem cell expansion and disturbed tissue architecture. This may be caused by mutations of pathway components or by autocrine signaling due to constitutive Wnt production by tumor cells (Clevers, 2006) . A key step in this pathway is the regulation of cytosolic b-catenin levels (MacDonald et al., 2009 ). In the absence of Wnt, a multiprotein complex phosphorylates b-catenin and constantly targets it for degradation. Key elements of this ''destruction'' complex are scaffold proteins, such as adenomatous polyposis coli (APC) and Axin, and the b-catenin phosphorylating kinases glycogen synthase kinase 3 (GSK3) and casein kinase 1 (CK1) (MacDonald et al., 2009) . GSK3 phosphorylation of b-catenin is critical for recognition by the F box protein b-TrCP and its associated E3 ubiquitin ligase complex (Liu et al., 2002) . Wnt signaling inhibits b-catenin phosphorylation through sequestration of GSK3 into multivesicular compartments and other mechanisms. This causes b-catenin to escape from b-TrCP recognition, leading to its accumulation and formation of a nuclear complex with the DNA-binding transcription factors TCF/Lef (Li et al., 2012; Niehrs and Acebron, 2012; Taelman et al., 2010) .
Wnt/TCF/b-catenin target genes account for important aspects of Wnt biology, an example being upregulation of c-myc or cyclin-D1 in some tumors. Yet, it is also increasingly evident that the highly temporal-and cell-specific expression of the known Wnt/TCF/b-catenin targets can hardly capture the pervasiveness and complexity of Wnt/b-catenin biology (Barolo, 2006; Niehrs and Acebron, 2012) . This raises the possibility that other factors, in addition to b-catenin/TCF, may contribute to Wntinduced biological responses.
Independently of Wnt signaling, the transcriptional coactivators TAZ and YAP have recently emerged at the centerpiece of poorly understood mechanisms that control tissue growth and organ size (Pan, 2010) . TAZ and YAP promote cell proliferation and inhibit differentiation, particularly in stem cells and organspecific progenitors, and therefore, their activity must be finely tuned in order to avoid loss of tissue regeneration and, at the other extreme, overgrowth and emergence of tumors (Ramos and Camargo, 2012) . Furthermore, TAZ has been recently proposed to endow self-renewal capacity to cancer stem cells (Bhat et al., 2011; Cordenonsi et al., 2011) .
TAZ and YAP are well known for their regulation by the Hippo pathway; the activation of two kinases, MST1/2 (homolog of Drosophila Hippo) and LATS1/2, leads to LATS-dependent phosphorylation of TAZ and YAP, limiting their stability, nuclear localization, and transcriptional activity (Pan, 2010) . Recent findings have emphasized the roles of cell polarity or cell-cell adhesion as upstream regulators of the Hippo kinases Varelas et al., 2010b) . Moreover, TAZ and YAP can (A) HEK293 cells were transfected with 8xGTIIC-Lux and either with control (siCo, lanes 1-3) or TAZ siRNAs (siTAZ, lane 4). After transfection, cells were exposed to control-(Co) or Wnt3A-conditioned medium. Where indicated, XAV939 (1 mM, lane 3) was added. Top: luciferase assay of the indicated samples. Data are normalized to lane 1 and are presented as mean +SD. Bottom: representative western blots for TAZ, YAP, b-catenin, and GAPDH (loading control) in the same extracts used for the luciferase assay. See also Figure S1B for the validation of Wnt activity in conditioned media and of XAV939 efficacy on a b-catenin/TCFluciferase reporter. (B) Wnt-induced transcriptional activation of 8xGTIIC-Lux (as in [A] ) is independent of b-catenin. (C) Top: luciferase assay on 8xGTIIC-Lux reporter recording TAZ-dependent transcriptional activity in HEK293 cells transfected with control (lanes 1 and 2), GSK3 (lanes 3 and 4), APC (lanes 5 and 6), or Axin (lanes 7 and 8) siRNAs, either alone or with TAZ siRNA, as indicated. Data are normalized to lane 1 and are presented as mean +SD. See Figures S1E, S1F, S1I, and S1K for siRNA validations. Bottom: western blot for TAZ in the same extracts used for the luciferase assay.
be regulated independently from the Hippo kinases by mechanical and architectural cues, such as cytoskeletal tension and cell shape (Dupont et al., 2011; Halder et al., 2012) .
Interestingly, there are-at least superficially-clear elements of overlap between b-catenin and TAZ or YAP; biochemically, all are short-lived proteins in the cytoplasm, as they are degraded by the same b-TrCP ubiquitin ligase complex (Liu et al., 2010; MacDonald et al., 2009; Zhao et al., 2010) . Biologically, they appear to control overlapping processes in a number of epithelial and nonepithelial contexts. Although this hints at some form of joined regulation, the possibility that Wnt could signal through TAZ or YAP stabilization has not been explored.
Here, we report the characterization of TAZ as a downstream component of Wnt/b-catenin signaling cascade. We show that Wnt induces TAZ protein stabilization and transcriptional activity in multiple cell types and that this is essential for distinct biological effects induced by Wnt signaling. We found that the same destruction complex responsible for b-catenin degradation also restrains TAZ protein levels. Yet, TAZ does not require direct phosphorylation by GSK3; rather, it is GSK3-phosphorylated b-catenin that serves as a scaffold for TAZ association with b-TrCP/E3 ubiquitin-ligase complex. By inhibiting b-catenin phosphorylation, Wnt promotes not only b-catenin stabilization but also TAZ accumulation and activation of TAZ-dependent gene responses.
RESULTS

Wnt
Activates TAZ This study was initiated by the discovery that treatment of HEK293 cells with Wnt3A triggered a remarkable increase of TAZ protein levels ( Figure 1A , bottom). Because TAZ mRNA levels were not affected by Wnt3A (Figure S1A available online) and because TAZ has been shown to be an unstable protein (Liu et al., 2010 ; data not shown), this suggested that Wnt3A promoted TAZ protein stabilization. In contrast, Wnt3A had no overt effect on YAP steady-state protein levels. Importantly, Wnt3A also triggered a robust induction of transfected 8xGTIIC-Lux ( Figure 1A , compare lanes 1 and 2), a synthetic luciferase sensor containing multimerized responsive elements of TEAD, the main DNA-binding cofactor of TAZ or YAP (Dupont et al., 2011) . This induction was dependent on stabilization of TAZ, as depletion of endogenous TAZ was sufficient to abolish the effect of Wnt3A ( Figure 1A , compare lanes 2 and 4), prompting us to investigate the link between Wnt and TAZ. Knockdown of b-catenin had no effect on the induction of 8xGTIIC-Lux by Wnt, ruling out that Wnt regulates TAZ stability indirectly, for example, through b-catenin target genes ( Figure 1B) . We also tested the possibility that Wnt might regulate TAZ by inhibiting the Hippo kinase cascade. As shown in Figure S1C , treatment with Wnt3A ligand could still induce TAZ in LATS1/2-depleted cells, indicating that LATS activity is not crucial for TAZ regulation by Wnt. We also expressed in HEK239 cells a phosphomutant TAZ protein lacking all LATS phosphorylation sites (TAZ 4SA); as expected, TAZ 4SA is more stable than wild-type TAZ, and yet it remains sensitive to Wnt regulation ( Figure S1D ). Taken together, these data suggested that Wnt signaling stabilizes and activates TAZ by mechanisms other than regulation of the Hippo pathway.
Wnt ligands are transduced intracellularly through the inactivation of the b-catenin destruction complex, which includes GSK3, APC, and Axin (MacDonald et al., 2009) . We sought to determine whether Wnt regulates TAZ through the same pathway. We thus reactivated the b-catenin destruction complex in Wnt-treated cells by using XAV939, a small molecule that promotes Axin stabilization (Huang et al., 2009) . XAV939 inhibited the effects of Wnt3A on TAZ transcriptional activity and stability ( Figure 1A , compare lanes 2 and 3). Conversely, depletion of Axin, GSK3, or APC induced TAZ stabilization and activity (Figure 1C) , phenocopying Wnt stimulation. As a control, depletion of LATS was irrelevant for TAZ regulation by GSK3 or APC (data not shown), again indicating that activation of TAZ by the Wnt signaling cascade does not rely on Hippo pathway inhibition. Thus, Wnt signaling regulates TAZ in a way that depends on the b-catenin destruction complex.
Next, we tested the validity of this conclusion in a different cellular model system. In transformed mammary epithelial cells (MCF10A-T1k or MII cells), knockdown of GSK3, APC, or Axin caused robust TAZ stabilization ( Figures 1D, S1F , S1H, and S1J) and promoted TAZ-dependent upregulation of CTGF (Figures 1E and S1L) , an established endogenous readout of TAZ activity . This was paralleled by nuclear accumulation of endogenous TAZ ( Figure 1F ).
Next, we wished to investigate to what extent Wnt gene responses are mediated by TAZ on the transcriptomic scale. For this, we compared the Affymetrix gene expression profiles of MII cells transfected with control small interfering RNA (siRNA), APC siRNA, or the combination of APC and TAZ siRNAs. We first identified a list of 739 probesets upregulated more than two times after APC depletion, thus entailing Wnt-induced target genes. Strikingly, 54% of these probesets were upregulated in a TAZ-dependent manner ( Figure 1G ); if we restricted our analyses to genes upregulated more than five times by APC knockdown, out of 132 probesets, 91 (70%) were TAZ dependent. These results indicate that TAZ is a relevant mediator of Wntinduced transcriptional responses in this cellular context.
We also found that Wnt pathway activation, either by stimulation with Wnt3A or by intracellular inhibition of the destruction complex, led to TAZ stabilization and induction of TAZ-dependent gene responses in a variety of cell types, such as in HeLa cervical carcinoma cells, HaCaT immortalized keratinocytes, primary human mesenchymal stem cells, mouse embryonic stem (ES) cells, and P19 mouse embryonic carcinoma cells ( Figures 1H, 1I, and S1N ). In sum, TAZ activation by Wnt is a general phenomenon irrespective of cell transformation, epithelial or mesenchymal status, and embryonic lineage.
Finally, to extend our finding to in vivo conditions, we crossed mice bearing APC floxed alleles (APC fl/fl ) with transgenic mice carrying the inducible Ah-Cre recombinase, in which robust Cre expression in liver, gut, and other organs can be induced by the drug b-naphtophlavone (see Extended Experimental Procedures). In liver extracts, genetic inactivation of APC triggered, as expected, the induction of the b-catenin/TCF target Cyclin-D1 ( Figure S1O ) and also triggered a strong upregulation of TAZ protein levels and of the TAZ targets Cyr61 and CTGF, but not of TAZ mRNA ( Figures 1J-1L and S1P).
Taken together, the data indicate that Wnt activity is a general inducer of TAZ stabilization and TAZ-dependent transcription, that TAZ regulation accounts for a significant portion of Wntregulated genes, and that TAZ levels are kept low by the same set of core proteins-Axin, APC, and GSK3-that continually keep b-catenin levels in check.
TAZ Mediates Wnt Biological Responses
Finding that the b-catenin destruction complex regulates TAZ carries a corollary: in APC mutant cells, TAZ should be already at the maximal level allowed by this regulation and thus should be insensitive to GSK3 inactivation. To test this hypothesis, we used the SW480 colorectal cancer (CRC) cell line, carrying a homozygous nonsense mutation in APC (Faux et al., 2004) . Indeed, depletion of GSK3 had no effect on TAZ stability in SW480 cells (Figure 2A , compare lanes 1 and 2). However, adding back APC to SW480 cells not only dramatically downregulated TAZ protein levels and the expression of TAZ target genes ( Figure 2A , compare lanes 1 and 3) but also restored sensitivity to GSK3 inhibition ( Figure 2A , compare lanes 3 and 4). Thus, aberrant Wnt signaling in CRC cells entails TAZ stabilization.
b-catenin is a key player downstream of oncogenic Wnt signaling for the growth of CRC cells (van de Wetering et al., 2002) . Here, we asked whether TAZ might also have important functions in this context. Knockdown of either TAZ or b-catenin reduced the proliferation of parental SW480 cells to a similar extent, with dual depletion of b-catenin and TAZ being required for a complete growth arrest ( Figure 2B , lanes 2-4). APC reconstitution led to a severe growth suppression ( Figure 2B , compare lanes 1 and 5), as previously reported (Faux et al., 2004) ; forced expression of TAZ rescued proliferation of APC-reconstituted SW480 cells (lane 6). Of note, manipulation of the levels of TAZ (by gain or loss of function) does not influence b-catenin levels ( Figure S2B ), suggesting that TAZ does not operate through b-catenin stabilization. Furthermore, loss of TAZ does not modify the expression of Axin2 and Cyclin-D1, two of the most established readouts of the TCF/b-catenin complex, ruling out that TAZ is required for TCF-dependent transcription ( Figure 2C ). Taken together, these data suggest that TAZ is essential and instrumental for cell proliferation downstream of aberrant Wnt signaling, cooperating with the well-established function of b-catenin in this process.
Parental SW480 cells are highly transformed and able to grow as clonal ''spheroids'' in Matrigel ( Figure 2E ). Consistently with the role of Wnt signaling as promoter of clonogenic potential (Niehrs and Acebron, 2012) , we found that the status of APC also contributes to the capacity of SW480 cells to grow under 3D conditions. Indeed, APC-reconstituted SW480 cells formed a much-reduced number of colonies than parental SW480 cells (Figures 2D, 2E, and 2H) . Remarkably, TAZ depletion in parental SW480 cells impaired spheroid formation, whereas knockdown of b-catenin did not ( Figures 2E-2H ). In sum, APC deficiency empowers 2D cell growth in a manner that is dependent both on b-catenin and on TAZ, as well as clonogenic properties, which are prevalently dependent on TAZ stabilization.
We then wished to assess, beyond any specific functional assay, what is the relative contribution of b-catenin and TAZ to the global Wnt gene response in CRC cells. For this, we compared the Affymetrix gene expression profiles of parental, TAZ-depleted, b-catenin-depleted, and APC-reconstituted SW480 cells. Importantly, we found that b-catenin and TAZ accounted for one-third and one-sixth of the $3,000 probesets modulated by APC reconstitution, respectively (p values < 10 À32 ). This indicates that TAZ targets represent a substantial fraction of gene expression driven by oncogenic APC.
TAZ Is Required for Wnt-Dependent Differentiation of Mesenchymal Stem Cells
We next addressed the role of TAZ as a downstream mediator of Wnt signals during Wnt-dependent differentiation of mesenchymal stem cells (MSC). Wnt signaling is indeed critical for bone formation in mammals, and, at least in part, this is due to the requirement of Wnts to promote an osteogenic lineage in mesenchymal progenitors (Leucht et al., 2008) . To address the role of TAZ in this process, we used ST-2 murine bone marrow stromal cells and primary human MSC. In mouse ST-2 cells, treatment with recombinant Wnt3A caused a robust increase in alkaline phosphatase (ALP), a marker of bone differentiation ( Figure 3A , top, compare lanes 1 and 3). Notably, this occurred with a parallel rise of b-catenin and TAZ protein levels ( Figure 3A , bottom). Strikingly, TAZ depletion had no effect on b-catenin levels but was sufficient to impair ALP induction by Wnt3A (lane 4), indicating that TAZ is an essential mediator of bone differentiation induced by Wnt in this cellular context.
Human MSC can be induced to differentiate into the osteoblast lineage by switching their culturing condition from regular growth medium to osteogenic differentiation medium. Addition of recombinant Dkk-1, an extracellular Wnt antagonist, severely impaired bone differentiation ( Figures 3B-3D ), a finding in line with the notion that autocrine Wnt ligands are essential for this process. Interestingly, we found that TAZ protein levels rose upon switching cells in osteogenic medium, but this was blocked by concomitant addition of Dkk-1 ( Figure 3F , compare lanes 1, 2, and 3). If, as previously implicated in ST-2 cells, TAZ induction is instrumental for bone differentiation downstream of Wnt, then raising TAZ levels should bypass the extracellular block posed by Dkk-1. For this experiment, we sustained TAZ expression by transducing MSC with a TAZ lentiviral vector ( Figure 3F , lane 4). Crucially, reconstitution of TAZ restored bone differentiation of Dkk1-treated hMSC ( Figure 3E ; see quantifications in Figure S3B ). Interestingly, the TAZ targets CTGF and Cyr61 were induced during osteogenic differentiation of MSC in a manner that was TAZ dependent, opposed by Dkk-1, and rescued by exogenous TAZ (Figures 3A and 3F ). Taken together, the data reveal that Wnt promotes MSC differentiation into osteoblasts through TAZ stabilization.
Contrary to bone differentiation, adoption of an adipogenic fate by MSC is inhibited by Wnt (Ross et al., 2000) , and loss of Axin, GSK3, or APC severely blunted adipocytic differentiation ( Figures 3G, 3H , and S3C-S3G). This inhibition was mediated by upregulation of endogenous TAZ as double depletion of Axin, and TAZ restored adipocyte differentiation (Figures 3I and 3J) . Similar results were obtained by double knockdowns of TAZ and GSK3 or TAZ and APC (data not shown). These epistatic relationships reinforce the notion that regulation of TAZ by the Wnt pathway is functionally relevant for MSC differentiation.
Role of GSK3 in TAZ Degradation
Next, we sought to determine by which mechanism Wnt signaling promotes TAZ activity. The results described so far suggested that stabilization of b-catenin and TAZ are both downstream of Wnt signaling because both proteins are degraded by the same destruction complex. The view that TAZ follows the same steps of b-catenin on its route to degradation is sug- Figure S4A ).
The interaction of b-catenin with b-TrCP occurs upon phosphorylation by GSK3 (MacDonald et al., 2009 ). We then tested whether GSK3 phosphorylation and b-TrCP recognition also drive TAZ degradation. We first tested this hypothesis by assaying whether the interaction of TAZ with b-TrCP required GSK3. Indeed, endogenous b-TrCP failed to associate to TAZ in coimmunoprecipitation assays from lysates of GSK3-depleted MII cells ( Figure 4B ). Moreover, GSK3 kinase activity is essential for TAZ degradation; knockdown of GSK3 stabilized TAZ in MII cells ( Figure 4C , lanes 1 versus 2 and 4 versus 5), and reconstitution with wild-type GSK3 ( Figure 4C , lane 3), but not with kinase-dead GSK3 ( Figure 4C , lane 6), rescued TAZ levels and activity. Similar results were obtained in HEK293 cells ( Figure S4B ). These findings are in line with the effect of CHIR99021, a small-molecule inhibitor of GSK3 enzymatic activity, leading to TAZ stabilization in a variety of cell types (Figure 1I ; data not shown).
GSK3 regulates the stability of b-catenin and other proteins through phosphorylation of a DSGXXS motif, called ''phosphodegron' ' (Taelman et al., 2010; Kim et al., 2009; Xu et al., 2009) . Phosphorylation of the two serines in the phosphodegron potentially tags a given protein for b-TrCP recognition, ubiquitination, and proteosomal degradation. Regulation of TAZ stability 1 and 3) or TAZ (lanes 2 and 4) siRNAs. Where indicated, cells were exposed to recombinant Wnt3A (lanes 3 and 4). Top: alkaline phosphatase (ALP) activity. Data are presented as mean +SD. Bottom: western blots for TAZ, Cyr61, and b-catenin in the corresponding extracts. GAPDH serves as loading control. Wnt3A does not affect TAZ mRNA levels ( Figure S3A ). (B-F) TAZ rescues bone differentiation in Dkk1-treated hMSC. hMSC, transduced with lentiviral vectors encoding for control (empty vector) or TAZ, were cultured either in growth medium (GM) or osteogenic differentiation medium (ODM); where indicated, Dkk-1 protein (500 ng/ml) was added to the ODM. (B-E) Representative fields of hMSC stained for ALP. See Figure S3B for quantifications of ALP-positive areas. (F) Western blots for TAZ, Cyr61, CTGF, and b-catenin in the samples described above. b-catenin was still inhibited by Dkk-1 in TAZ-transduced MSCs (lanes 3 and 4) . by GSK3 has been previously documented downstream of PI3K/AKT signaling through phosphorylation of an N-terminal phosphodegron motif, entailing S58 and S62 (Huang et al., 2012 ) (see Figure S4C ). This raised the possibility that, in analogy to b-catenin, GSK3 might promote TAZ degradation by phosphorylating these two sites also in the context of the Wnt cascade. If this were the case, mutation of those two residues from serine to alanine should render TAZ resistant to GSK3-mediated degradation. In stark contrast with this prediction, both wild-type and S58/62A TAZ were similarly stabilized by GSK3 knockdown ( Figure 4D ). Moreover, the activity of TAZ S58/62A could still be induced by Wnt3A ( Figure 4E ). We conclude that GSK3 keeps TAZ levels low irrespective of integrity of the N-terminal TAZ phosphodegron.
Taken together, the results indicated that, although GSK3 kinase activity is essential for TAZ association to b-TrCP, a mechanism entailing direct GSK3 phosphorylation of TAZ was unlikely. We thus considered that the effect of GSK3 on TAZ stability was primarily indirect, that is, through modification of an intermediary protein serving as adaptor for TAZ degradation. And, in the context of Wnt signaling, the most likely culprit was b-catenin itself, whose degradation is well known to require direct GSK3 phosphorylation.
b-Catenin Promotes TAZ Degradation By coimmunoprecipitation, we found that b-catenin and TAZ form a complex at endogenous protein levels ( Figures 5A and  S5A) , prompting us to test whether b-catenin was required for TAZ association to b-TrCP and TAZ degradation. Intriguingly, depletion of b-catenin by siRNA revealed that b-catenin was required for the endogenous association of TAZ to b-TrCP in MII cells ( Figure 5B ). Furthermore, knockdown of b-catenin by independent siRNAs caused a robust stabilization of TAZ protein, induction of TAZ transcriptional activity, and TAZ nuclear (C) GSK3 kinase activity is essential to dampen TAZ protein levels and function. MII cells were engineered to express doxycycline-inducible/siRNA-insensitive human GSK3b, either wild-type (wt; lanes 1-3) or kinase-dead mutant (KD; lanes 4-6). After depletion of endogenous GSK3 by siRNA transfection (lanes 2, 3, 5, and 6), cells were exposed to 0.5 mg/ml doxycycline to induce the expression of either wt GSK3b (lane 3) or KD GSK3b (lane 6). Lanes 1 and 4 are cells transfected with control siRNA. Top: quantitative real-time PCRs for CTGF (mean +SD). Bottom: western blots for TAZ and GSK3. Lane 1 versus 2 and lane 4 versus 5: TAZ is stabilized and activated (CTGF induction) upon GSK3 depletion; lane 3: reconstitution with wt GSK3b rescues the effect of GSK3 depletion; lane 6: reconstitution with KD GSK3b has no effect. (D) GSK3 regulates TAZ independently of its phosphodegron. Lanes 1 and 2: western blot for endogenous TAZ shows its stabilization upon GSK3 depletion. Lanes 3-6: MII cells were transfected with TAZ siRNA (to avoid interference from regulations of endogenous TAZ) and reconstituted with siRNA-insensitive mouse TAZ, either wt (lanes 3 and 4), or S58/62A mutant (lanes 5 and 6). Both wild-type and S58/62A TAZ are sensitive to GSK3 siRNA. See Figures S4D and S4E for TAZ mRNA levels. (E) Wnt activates TAZ independently of its GSK3-phosphodegron. HEK293 cells were transfected with the synthetic 8xGTIIC-Lux reporter. Lanes 1 and 2: Wnt3A-conditioned medium activates the reporter. Lanes 3 and 4: knockdown of endogenous TAZ abolishes the effect of Wnt. Lanes 5-8: cells were transfected with TAZ siRNA to avoid interference from regulations of endogenous TAZ and were reconstituted with either mouse wt TAZ (lanes 5 and 6) or TAZ S58/62A (lanes 7 and 8). The phosphodegron is irrelevant for TAZ activation by Wnt (lanes 6 and 8). Bars are mean +SD. See also Figure S4 . accumulation ( Figures 5C-5E and S5B ). Of note, loss of b-catenin was not accompanied by events known to regulate TAZ through the Hippo pathway , that is, downregulation of cadherin adherens junctions, epithelial-mesenchymal transition, disturbed apico-basal polarity, or changes in the levels of active LATS ( Figures S5C and S5D) .
Our results thus suggested a model whereby b-catenin plays a central role in TAZ inhibition by bridging TAZ to the b-TrCP complex ( Figure 6A, left) . In this scenario, a TAZ mutant that cannot interact with b-catenin should not bind b-TrCP, nor should it be regulated by Wnt signaling. To validate this notion, we carried out mapping studies by using recombinant GST-TAZ deletion constructs and in-vitro-translated b-catenin. The results revealed that the ''WW'' domain of TAZ was required for association to b-catenin ( Figure S5E ). Once expressed in human cells not experiencing Wnt signaling, TAZ deleted of the WW domain (TAZDWW) was more stable and basally more active than wild-type TAZ ( Figures 5G and S5F) , correlating with the incapacity of TAZDWW to associate to endogenous b-catenin and b-TrCP ( Figure 5F ). As predicted, TAZDWW could not be further stabilized nor activated by Wnt signaling (Figure 5G) . Critically, the hyperactive behavior of TAZDWW could not be ascribed to an escape from the Hippo pathway, as TAZDWW is still phosphorylated on the leading LATS target S306 and can be further stabilized by LATS1/2 depletion ( Figures  S5G and S5H) . We conclude from these structure-function experiments that, in Wnt-OFF cells, b-catenin bridges TAZ to b-TrCP ( Figure 6A, left) . Activation of the Wnt pathway reduces such association of b-catenin to b-TrCP and, consequently, dampens TAZ degradation ( Figure 6A, middle) .
In the Wnt-OFF world, cytoplasmic b-catenin is recruited to b-TrCP after being phosphorylated by GSK3, whose kinase activity is also critical for TAZ degradation (Figure 4) . Is the GSK3-phosphorylated pool of b-catenin the ultimate mediator of TAZ degradation? For this, we analyzed TAZ stability and CTGF induction in two MII cell lines, which were depleted of endogenous b-catenin and reconstituted at near-to-endogenous levels with either wild-type b-catenin or a phosphomutant b-catenin ( Figure 6B ). This mutant harbors N-terminal point mutations (serine to alanine, S/A) that prevent GSK3 phosphorylation and b-TrCP recognition (Liu et al., 2002) . As above, knockdown of b-catenin promoted TAZ stabilization in both MII derivatives ( Figure 6B , lanes 1 and 2 and lanes 4 and 5); adding back wild-type b-catenin rescued TAZ degradation ( Figure 6B , lane 3). However, reconstitution with S/A phosphomutant b-catenin had no effect ( Figure 6B , lane 6), indicating that TAZ degradation relies on b-catenin phosphorylation by GSK3. In these experiments, changes in TAZ protein levels were consistently paralleled by changes in its activity, as indicated by the expression of its target CTGF ( Figure 6B ).
Further support to the model proposed in Figure 6A was provided by experiments in HepG2 hepatoma cells. These cells carry two different b-catenin alleles: one encoding wild-type b-catenin and the other encoding a constitutively active b-catenin bearing a natural deletion in the N terminus encompassing the GSK3 phosphorylation sites ( Figure 6C ). We designed a siRNA oligonucleotide (#4) that specifically binds within the deletion and, as such, only targets the wild-type and not the mutated allele. By using this siRNA, we found that the sole wild-type b-catenin is responsible for TAZ degradation (Figure 6D , compare lanes 1 and 5), as depletion of both isoforms does not further increase TAZ stability ( Figure 6D , compare lanes 1, 3, and 5). Conversely, b-catenin-dependent induction of one of its transcriptional targets, Cyclin-D1, is almost exclusively supported by the mutant allele ( Figure S6C) . Thus, the HepG2 model system allows uncoupling of the two functions of b-catenin: nuclear/transcriptional activity, a function almost exclusively mediated by the stabilized b-catenin, and TAZ degradation, which requires a phosphorylatable b-catenin.
We then asked whether the role of b-catenin as TAZ inhibitor is functionally relevant for TAZ activity. TAZ and Wnt have been independently proposed as critical factors in sustaining the self-renewal of normal and transformed mammary epithelial cells, as assessed in mammosphere assay Scheel et al., 2011) . For example, TAZ depletion impairs formation of mammospheres in cell populations enriched of prospective cancer stem cells, whereas gain of TAZ promotes mammosphere potential in otherwise non-stem-cell populations . In line with b-catenin depletion leading to TAZ stabilization, knockdown of b-catenin in MII cells caused an increase in mammosphere formation that was blunted upon concomitant depletion of TAZ ( Figure 6E ).
We next sought to determine to what extent b-catenin serves as endogenous TAZ inhibitor in cells lacking Wnt stimulation or oncogenic activation of the pathway. For this, we first monitored by microarray profiling the global transcriptional effects of b-catenin depletion in MII cells and then asked to what extent these were dependent on TAZ upregulation. We found that b-catenin depletion led to induction of about 350 probesets; a remarkable 74% of this list was TAZ dependent, as induction of these probesets was reverted by concomitant loss of TAZ ( Figure 6F ). Interestingly, >90% of the TAZ-dependent probesets upregulated by b-catenin depletion were also upregulated by APC depletion in a TAZ-dependent manner ( Figure 1G ) and, thus, represented targets of the following pathway:
The results collectively indicate that APC-regulated cytoplasmic b-catenin, so far considered transcriptionally irrelevant and only meant to be degraded, is in fact a potent repressor of the TAZ transcriptional program.
g-Catenin Participates in TAZ Regulation g-catenin is a homolog of b-catenin, and the two proteins are thought to operate in an overlapping manner in several contexts: they have redundant functions in cell adhesion and share Wnt-dependent regulation through phosphorylation by GSK3 and b-TrCP-mediated degradation . Importantly, TAZ associates with g-catenin at endogenous protein levels ( Figure 6G) , and, similarly to b-catenin, this interaction is dependent on the integrity of the TAZ WW domain ( Figure S6F ). This prompted us to test whether g-catenin also shares with b-catenin the capacity to regulate TAZ. To examine this, we monitored TAZ activity in HEK293 cells transfected with siRNAs against b-catenin, g-catenin, or both. Depletion of g-catenin led to TAZ stabilization ( Figure 6H ) and TAZ-dependent transcriptional activity ( Figure 6I, lane 5) . Interestingly, concomitant depletion of both b-and g-catenin resulted in even stronger transcriptional activation ( Figure 6I ). This indicates that these factors play independent and additive roles in TAZ inhibition.
Finally, we tested whether depletion of g-catenin is sufficient to sustain the biological functions of TAZ even in the absence of Wnt stimulation. For this, we chose to monitor osteogenic differentiation of bone marrow cells that-as shown above (Figure 3) -is promoted by Wnt through TAZ stabilization. Indeed, depletion of g-catenin in murine bone marrow stromal cells induced a robust increase of TAZ protein and TAZ-dependent activation of the osteogenic program ( Figure 6J ). This activity closely resembles the effects of Wnt ligands and suggests that b-catenin and its homolog g-catenin play a relevant role in the control of TAZ stability and activity.
DISCUSSION
In this work, we have presented evidence indicating that TAZ is downstream of Wnt signaling and is critical for some established Wnt-dependent biological responses.
Inhibition of the b-catenin destruction complex is central to Wnt signaling; this results in b-catenin stabilization. In this classic view, b-catenin is the last known element of the Wnt signaling cascade. Here, we reveal the existence of a new downstream Figure S6A ). (C) Scheme of the two transcripts (and protein products) encoded by the wt (black) and exon3/exon4-deleted (del ex3-4, blue) b-catenin alleles of HepG2 cells. The phosphodegron site on wild-type b-catenin, missing in the mutant protein, is in orange. The regions of b-catenin mRNA targeted by siRNAs are indicated in red; as the sequence targeted by siRNA#4 is within the deletion, this siRNA only hits the wild-type transcripts, whereas siRNA#3 is used to deplete both isoforms.
(legend continued on next page) layer in this cascade, revealing a key role for b-catenin in regulating the stability of another potent transcriptional coactivator, TAZ.
TAZ as a Downstream Mediator of Wnt Signaling
The results shed new light on the modalities by which the Wnt pathway controls gene expression. Prior to this work, we could have equated the Wnt signal only to the genes controlled by b-catenin through its association to TCF/Lef. Here, we show that formation of the b-catenin/TCF complex is not the sole modality by which the Wnt/b-catenin pathway can regulate gene expression, as we found that TAZ protein stabilization and TAZ-mediated transcription are also a general feature of the Wnt response in a variety of cellular model systems. It is noteworthy that, when we challenged by gene expression profiling the global relevance of TAZ downstream of Wnt signaling, that is, in a manner that goes beyond by the use of specific bioassays or genetic sensors, the regulation of a very significant fraction of Wnt target genes turned out to be TAZ dependent both in mammary epithelial cells and in colorectal cancer cells.
We propose that Wnt signaling has thus two consequences: to turn on the transcriptional functions of b-catenin, as so far acknowledged, and to turn on the transcriptional functions of TAZ. The specific relevance of these two aspects will likely depend on the cellular context. In some cell types, or experimental conditions, the effects of Wnt may primarily depend on TCF-dependent transcription. However, we reason that the most likely situation will be one in which both b-catenin-and TAZ-dependent biological effects are occurring at the same time in response to Wnt pathway activation. For example, in colorectal cancer cells, the presence of oncogenic mutations in APC potently stabilizes both b-catenin and TAZ, with both factors sustaining cell proliferation. Still, even in this oncogenic setup, we could highlight a specific role of TAZ in endowing clonogenic potential to CRC cells, a function not shared by stabilized b-catenin. Similarly, TAZ plays essential roles in the regulation of mesenchymal stem cell differentiation, likely in concert with, and complementary to, b-catenin. Makita et al. (2008) reported that a minor fraction of TAZ mutant mice develop to term, suggesting that TAZ may primarily contribute to Wnt responses in adult tissues. It must be also noticed, however, that the vast majority of TAZ mutants die in utero with an as-yet-uncharacterized phenotype (Makita et al., 2008) ; in fact, we have been unable to obtain any TAZ À/À newborn in our colony (L.A. and S.P., unpublished data) . This leaves open the potential of an overlap between Wnt and TAZ also in embryonic development, perhaps consistently with the severe phenotype of TAZ-deficient zebrafish embryos (Hong et al., 2005) .
TAZ and its related protein YAP are functionally redundant during embryonic development, with double knockouts failing to form the blastocyst (Nishioka et al., 2009) . In this work, we have focused on TAZ because of its overt stabilization by Wnt signaling and functional relevance in Wnt bioassays. A question is whether YAP may be also controlled by Wnt through similar or unrelated mechanisms; of note, a complex between b-catenin and YAP has been previously reported (Imajo et al., 2012) . Although we failed to detect changes in YAP protein steadystate levels upon Wnt signaling, YAP stability may be regulated more finely or at the level of nuclear activity and nucleo-cytoplasmic localization. Dedicated studies are required to dissect these possibilities.
A New Role for b-Catenin
Here, we propose a distinct perspective on Wnt signaling whereby b-catenin plays active roles both in the presence and absence of Wnt ligands ( Figure 6A ). In the absence of Wnt signaling (i.e., Wnt OFF state), the pool of phospho-b-catenin is an essential element for continuous TAZ degradation, as it serves as critical scaffold for TAZ recognition by the b-TrCP E3 ubiquitin ligase. This configures an unexpected role for cytoplasmic b-catenin: besides being recruited to the destruction complex for its own degradation, b-catenin works as yet another intermediary of the Wnt cascade upstream of TAZ. Much evidence supports this conclusion, including (1) TAZ and b-catenin form a complex at endogenous protein levels in unstimulated cells; (2) b-catenin phosphorylation is required for TAZ degradation; and (3) depletion of both GSK3 and b-catenin impairs TAZ/ b-TrCP interaction.
One possible interpretation of these results would be that TAZ could only bind the phosphorylated form of b-catenin. However, TAZ and b-catenin proteins can associate in vitro, arguing against a strict requirement of b-catenin phosphorylation. Another equally plausible interpretation is that, irrespectively of b-catenin phosphorylation per se, TAZ may effectively associate to b-catenin only after cytoplasmic b-catenin is captured by the destruction complex, a scenario that is compatible with other proteins of the destruction complex either reinforcing the b-catenin/TAZ interaction or escorting the b-catenin/TAZ/b-TrCP recognition.
The relevance of b-catenin as endogenous inhibitor of TAZ was validated at the genome-wide level in mammary epithelial cells by microarray experiments. These analyses uncovered that APC-regulated cytoplasmic b-catenin, per se transcriptionally irrelevant, does nevertheless actively control gene expression, as it restrains the TAZ-dependent gene expression program ( Figure 6F ). As proof of principle of the functional relevance of this inhibition, we used an established TAZ biological assay (mammosphere assay; Cordenonsi et al., 2011) and confirmed that b-catenin depletion enhances TAZ activity in mammary epithelial cells.
g-catenin represents yet another variation on this scenario; this b-catenin-related protein is regulated by the Wnt/GSK3/ b-TrCP axis, but its relevance for TCF-dependent transcription is still debated (Ben-Ze'ev, 1999) . Nevertheless, here we show that g-catenin is able to regulate TAZ-dependent transcriptional responses by promoting TAZ instability in concert, or redundantly, with b-catenin. From this ''TAZ perspective,'' g-catenin may effectively be part of the Wnt response.
We propose that, in cells experiencing Wnt activity, b-catenin, per se largely dissociated from b-TrCP, is incapable of carrying out any adaptor function for TAZ and, as such, is irrelevant for TAZ regulation ( Figure 6A ). In this view, it is the loss of the association of phospho-b-catenin to b-TrCP that causes TAZ stabilization; we found that TAZ is indeed stabilized not only by Wnt signaling but also by experimental removal of b-catenin (Figure 6A , middle and right). It also follows that removing b-catenin from cells where the fraction of phospho-b-catenin is negligible-such as Wnt-treated cells or cells carrying oncogenic APC-is inconsequential for an already stabilized TAZ protein.
In fact, b-catenin knockdown cannot further increase TAZ levels in APC-deficient SW480 colon cancer cells ( Figure S2B , lane 3) nor TAZ-dependent transcription in Wnt-stimulated HEK293 cells ( Figure 1B, lane 3) .
The functions of the two pools of b-catenin could be visualized at the endogenous level and within the same cellular context by using HepG2 cells, which contain both wild-type and a nonphosphorylatable mutant b-catenin. In line with our model, only wildtype b-catenin is relevant to oppose TAZ; mutant-b-catenin is unable to bring TAZ to degradation, whereas it mediates the b-catenin/TCF transcriptional responses.
TAZ Stability at the Crossroad between Wnt and Hippo Signaling Cell-cell adhesion and polarity cues activate the Hippo/LATS kinases, leading to TAZ phosphorylation and sequestration in the cytoplasm Pan, 2010) . More recently, a largely LATS-independent modality to regulate TAZ stability and activity has been also shown to occur as consequence of changes in cell shape and cytoskeletal reorganization induced by mechanical cues, such as rigidity of the extracellular matrix (Dupont et al., 2011) . Here, we further expanded the landscape of TAZ regulation by showing that TAZ is controlled by a major family of secreted growth factors in a manner largely independent from Hippo signaling. This network accommodates self-regulating feedback loops; TAZ was demonstrated to negatively regulate the Wnt pathway by inhibiting Dishevelled, a positive Wnt regulator (Varelas et al., 2010a) . This may provide a ceiling to the levels of TAZ activation by Wnts and a mechanism to turn off TAZ-dependent responses.
One point worth discussing is that TAZ is phosphorylated by LATS and CK1 to generate a C-terminal phosphodegron that has been shown to be relevant for TAZ stability and to promote direct association to b-TrCP, at least under conditions of protein overexpression (Liu et al., 2010) . This is apparently at odds with the present findings indicating that, at endogenous protein levels, TAZ and b-TrCP associate indirectly through a b-catenin bridge. In fact, these two scenarios are perfectly compatible, as these represent formally independent modalities of regulating TAZ stability by the Hippo and Wnt cascades, respectively. Indeed, here we show that LATS inhibition or mutation of the LATS or CK1 phosphorylation sites are irrelevant for TAZ regulation by Wnt (Figures S1C and S1D ; data not shown); conversely, a TAZ mutant unable to bind b-catenin is insensitive to Wnt but remains under LATS1/2 control. Taken together, these findings open very intriguing possibilities for TAZ as a hub integrating different physiological inputs.
Finally, having established TAZ as Wnt effector opens up many therapeutic possibilities. Targeting TAZ could curb aberrant Wnt signaling in a variety of cancers and other disorders. Conversely, targeting the Wnt pathway by restoring the integrity of the destruction complex would effectively inhibit, at once, two of the most potent oncogenic drivers of human malignancies.
EXPERIMENTAL PROCEDURES Luciferase Assays
Luciferase reporters (50 ng/cm 2 ) were transfected together with CMV-b-gal (75 ng/cm 2 ) to normalize for transfection efficiency with CPRG (Roche) colorimetic assay. For luciferase assays in siRNA-depleted cells, cells were first transfected with the indicated siRNAs and, after 24 hr, were transfected with plasmid DNA. Where indicated, cells were exposed to control-or Wnt3A-conditioned medium for 24 hr before harvesting. Each sample was transfected in duplicate, and each experiment was repeated at least three times independently. siRNA sequences are listed in Table S1 .
MSC Differentiation Assays
For bone differentiation of ST-2 mouse cells, cells were cultured in the presence of 100 mg/ml ascorbic acid (Sigma) and 5 mM b-glicerophosphate (Sigma), alone or in combination with 100 ng/ml recombinant Wnt3A (Peprotech) for 72 hr. Cells were then harvested in 0.5% Triton X-100, and alkaline phosphatase (ALP) activity was assessed by measuring spectroscopycally at 405 nm the hydrolysis of p-nitrophenyl phosphate (Sigma) to p-nitrophenol (expressed as nmol/min/mg protein) after a 10 min incubation at room temperature. Data were normalized to the total protein content, determined by Bradford. For bone differentiation of hMSC, cells were switched from growth medium (GM) to osteogenic differentiation medium (ODM) 24 hr after seeding; medium was then renewed every 2 days for a total of 10 days of differentiation. MSC were then fixed and assayed by ALP staining kit (Sigma 85L2).
Adipogenic differentiation of hMSC and quantifications of ALP-positive or oil-red-positive areas were carried out as in Dupont et al. (2011) .
Western Blot, Immunoprecipitation, and qPCR MII cells were grown for 2 days at high density. Extracts and total RNA were prepared and analyzed as in Cordenonsi et al. (2011) . Immunoprecipitations were carried out as in Cordenonsi et al. (2011) by using the anti-TAZ monoclonal antibody from BD Biosciences, the anti-b-catenin monoclonal antibody (E-5) from Santa Cruz, or the anti-Flag-tag monoclonal antibody (M2) from Sigma. See also Extended Experimental Procedures.
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